The Use of Homeopathic-Based Treatment Approaches to Reduce the Prevalence of Malaria in Depressed Communities
Launched by MALAMED · Jul 11, 2006
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
The main objective of this project is to evaluate the efficacy, costs and benefits of homeopathic treatment therapies.This study will be conducted in the Kroo Bay community within Freetown, the capital city of Sierra Leone. This is a region where malaria is endemic with an annual average of one malaria episode per person.Further, given the high rates of poverty, most residents cannot afford to purchase the conventional drugs used to treat the malaria. Chloroquine, which is the cheapest drug available, is no longer efficacious for P.falciparum parasites.
The study will utilize a longitudina...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Willingness to participate:
- • Ability to understand and sign consent form,
- • Permanent residence within 10km radius of Kroo Bay
- Exclusion Criteria:
- • Serious Underlying Illness,
- • Absence from the study for 4 months
About Malamed
Malamed is a leading clinical trial sponsor specializing in innovative healthcare solutions that advance medical research and patient care. With a commitment to ethical practices and scientific integrity, Malamed conducts rigorous clinical trials across various therapeutic areas, focusing on developing cutting-edge treatments and technologies. The organization collaborates with healthcare professionals, regulatory bodies, and research institutions to ensure the highest standards of quality and compliance. Driven by a mission to enhance health outcomes, Malamed is dedicated to translating scientific discoveries into real-world applications that improve the lives of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Freetown, , Sierra Leone
Patients applied
Trial Officials
Jacob Minah, MD
Principal Investigator
Specialist Pediatrician, Homeopath, Germany
Florence M. Margai, PhD
Principal Investigator
Professor, Binghamton University-New York
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials